Distinct DNA methylation profiles between adenocarcinoma and squamous cell carcinoma of human uterine cervix

Oncology Research

Volumn 18, Issue 9, 2010, Pages 401-408

  Lee, Eun Ju ^a,b   McClelland, Michael ^a   Wang, Yipeng ^a,c   Long, Fred ^a   Choi, Sang Ho ^a,d   Lee, Je Ho ^e,f  

^a Vaccine Research Institute of San Diego   (United States)

^b Chung Ang University College of Medicine   (South Korea)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d University of Ulsan College of Medicine   (South Korea)

^e Sungkyunkwan University   (South Korea)

^f Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Cervical cancer; DNA methylation; NOGOR; PAK6

Indexed keywords

FERROPORTIN 1; NOGO 66 RECEPTOR; OLIGONUCLEOTIDE; P21 ACTIVATED KINASE 6; PROTEIN FLNC; TUMOR MARKER; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ARTICLE; DNA FINGERPRINTING; DNA METHYLATION; GENE LOCUS; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

EID: 77952389985     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504010X12644422320744     Document Type: Article

References (27)

1. Jones, P. A.; Baylin, S. B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3:415-428; 2002.
2. Laird, P. W. The power and the promise of DNA methylation markers. Nat. Rev. Cancer 3:253-266; 2003.
3. Costello, J. F.; Frühwald, M. C.; Smiraglia, D. J.; Rush, L. J.; Robertson, G. P.; Gao, X.; Wright, F. A.; Feramisco, J. D.; Peltomäki, P.; Lang, J. C.; Schuller, D. E.; Yu, L.; Bloomfield, C. D.; Caligiuri, M. A.; Yates, A.; Nishikawa, R.; Su Huang, H.; Petrelli, N. J.; Zhang, X.; O'Dorisio, M. S.; Held, W. A.; Cavenee, W. K.; Plass, C. Aberrant CpG-island methylation has non-random and tumourtype-specific patterns. Nat. Genet. 24:132-138; 2000.
4. Esteller, M.; Com, P. G.; Baylin, S. B.; Herman, J. G. A gene hypermethylation profile of human cancer. Cancer Res. 61:3225-3229; 2001.
5. Wang, Y.; Yu, Q.; Cho, A. H.; Rondeau, G.; Welsh, J.; Adamson, E.; Mercola, D.; McClelland, M. Survey of differentially methylated promoters in prostate cancer cell lines. Neoplasia 7:748-760; 2005.
6. Zilberman, D.; Henikoff, S. Genome-wide analysis of DNA methylation patterns. Development 134:3959-3965; 2007.
7. Parkin, D. M.; Bray, F.; Ferlay, J.; Pisani, P. Global cancer statistics, 2002. CA Cancer J. Clin. 55:74-108; 2005.
8. Shingleton, H. M.; Gore, H.; Bradley, D. H.; Soong, S. J. Adenocarcinoma of the cervix. I. Clinical evaluation and pathologic features. Am. J. Obstet. Gynecol. 139:799-814; 1981.
9. Schoolland, M.; Allpress, S.; Sterrett, G. F. Adenocarcinoma of the cervix. Cancer 96:5-13; 2002.
10. Lea, J. S.; Sheets, E. E.; Wenham, R. M.; Duska, L. R.; Coleman, R. L.; Miller, D. S.; Schorge, J. O. Stage IIBIVB cervical adenocarcinoma: Prognostic factors and survival. Gynecol. Oncol. 84:115-119; 2002.
11. Smith, H. O.; Tiffany, M. F.; Qualls, C. R.; Key, C. R. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States-a 24-year population-based study. Gynecol. Oncol. 78:97-105; 2000.
12. Kang, S.; Kim, J. W.; Kang, G. H.; Lee, S.; Park, N. H.; Song, Y. S.; Park, S. Y.; Kang, S. B.; Lee, H. P. Comparison of DNA hypermethylation patterns in different types of uterine cancer: Cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma. Int. J. Cancer 118:2168-2171; 2006.
13. Lin, Z.; Gao, M.; Zhan, X.; Kim, Y. S.; Lee, E. S.; Kim, H. K.; Kim, I. The hypermethylation and protein expression of p16 INK4A and DNA repair gene O6-methylguanine-DNA methyltransferase in various uterine cervical lesions. J. Cancer Res. Clin. Oncol. 131:364-370; 2005.
14. Hoemme, C.; Peerzada, A.; Behre, G.; Wang, Y.; McClelland, M.; Nieselt, K.; Zschunke, M.; Disselhoff, C.; Agrawal, S.; Isken, F.; Tidow, N.; Berdel, W. E.; Serve, H.; Müller-Tidow, C. Chromatin modifications induced by PML-RARalpha repress critical targets in leukemogenesis as analyzed by ChIP-Chip. Blood 111:2887-2895; 2008.
15. Arora, S.; Wang, Y.; Jia, Z.; Vardar-Sengul, S.; Munawar, A.; Doctor, K. S.; Birrer, M.; McClelland, M.; Adamson, E.; Mercola, D. Egr1 regulates the coordinated expression of numerous EGF receptor target genes as identified by ChIP-on-chip. Genome Biol. 9:R166; 2008.
16. Albert, T. J.; Norton, J.; Ott, M.; Richmond, T.; Nuwaysir, K.; Nuwaysir, E. F.; Stengele, K. P.; Green, R. D. Light-directed 5′ → 3′ synthesis of complex oligonucleotide microarrays. Nucleic Acids Res. 31:e35; 2003.
17. Kent, W. J. BLAT - the BLAST-like alignment tool. Genome Res. 12:656-664; 2002.
18. Ihaka, I.; Gentleman, R. R: a language for data analysis and graphics. J. Comput. Graph. Stat. 5:299-314; 1996.
19. Smyth, G. K.; Speed, T. Normalization of cDNA microarray data. Methods 31:265-273; 2003.
20. Smyth, G. K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3:Article 3; 2004.
21. Shi, H.; Wang, M. X.; Caldwell, C. W. CpG islands: Their potential as biomarkers for cancer. Expert Rev. Mol. Diagn. 7:519-531; 2007.
22. Kaneda, A.; Kaminishi, M.; Sugimura, T.; Ushijima, T. Decreased expression of the seven ARP2/3 complex genes in human gastric cancers. Cancer Lett. 212:203-210; 2004.
23. Lind, G. E.; Skotheim, R. I.; Fraga, M. F.; Abeler, V. M.; Esteller, M.; Lothe, R. A. Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN-1). J. Pathol. 210:441-449; 2006.
24. Kaur, R.; Liu, X.; Gjoerup, O.; Zhang, A.; Yuan, X.; Balk, S. P.; Schneider, M. C.; Lu, M. L. Activation of p21-activated kinase 6 by MAP kinase kinase 6 and p38 MAP kinase. J. Biol. Chem. 280:3323-3330; 2005.
25. GrandPré, T.; Li, S.; Strittmatter, S. M. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 417:547-551; 2002.
26. Liao, H.; Duka, T.; Teng, F. Y.; Sun, L.; Bu, W. Y.; Ahmed, S.; Tang, B. L.; Xiao, Z. C. Nogo-66 and myelin-associated glycoprotein (MAG) inhibit the adhesion and migration of Nogo-66 receptor expressing human glioma cells. J. Neurochem. 90:1156-1162; 2004.
27. Wang, K. C.; Koprivica, V.; Kim, J. A.; Sivasankaran, R.; Guo, Y.; Neve, R. L.; He, Z. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 417:941-944; 2002.